Pregabalin does not bind to plasma proteins. Pregabalin is eliminated primarily by renal excretion as an unchanged drug and has an elimination half-life of approximately 6 h. [14] For patients ...

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

New Delhi, Apr 24 (PTI) Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of ...

The Dublin, Ireland-headquartered company said the resubmission will allow more time for the FDA to inspect a packaging and labelling manufacturing facility for the drug, which as a result of a ...

The drug is a therapeutic equivalent of Jynarque, developed by Otsuka, and is used to treat autosomal dominant polycystic kidney disease (ADPKD) — a chronic condition with limited treatment options.

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.

If this drug can improve the lifespan of transplants, the numbers waiting will be reduced and we won't have to carry out as many operations.' The drug works by interfering with the ability of the ...

With diabetes, ACE inhibitors don’t directly lower blood sugar, but they can contribute to blood sugar control and lower the risk of heart and kidney complications with diabetes. Off-label drug use is ...